Cargando…

Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3

Nucleobindin-2 (Nucb2) is a protein that has been suggested to play roles in a variety of biological processes. Nucb2 contains two Ca(2+)/Mg(2+)-binding EF-hand domains separated by an acidic amino acid residue-rich region and a leucine zipper. All of these domains are located within the C-terminal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bystranowska, Dominika, Skorupska, Anna, Sołtys, Katarzyna, Padjasek, Michał, Krężel, Artur, Żak, Andrzej, Kaus-Drobek, Magdalena, Taube, Michał, Kozak, Maciej, Ożyhar, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361300/
https://www.ncbi.nlm.nih.gov/pubmed/34429849
http://dx.doi.org/10.1016/j.csbj.2021.07.036
_version_ 1783737934373978112
author Bystranowska, Dominika
Skorupska, Anna
Sołtys, Katarzyna
Padjasek, Michał
Krężel, Artur
Żak, Andrzej
Kaus-Drobek, Magdalena
Taube, Michał
Kozak, Maciej
Ożyhar, Andrzej
author_facet Bystranowska, Dominika
Skorupska, Anna
Sołtys, Katarzyna
Padjasek, Michał
Krężel, Artur
Żak, Andrzej
Kaus-Drobek, Magdalena
Taube, Michał
Kozak, Maciej
Ożyhar, Andrzej
author_sort Bystranowska, Dominika
collection PubMed
description Nucleobindin-2 (Nucb2) is a protein that has been suggested to play roles in a variety of biological processes. Nucb2 contains two Ca(2+)/Mg(2+)-binding EF-hand domains separated by an acidic amino acid residue-rich region and a leucine zipper. All of these domains are located within the C-terminal half of the protein. At the N-terminal half, Nucb2 also possesses a putative Zn(2+)-binding motif. In our recent studies, we observed that Nucb2 underwent Ca(2+)-dependent compaction and formed a mosaic-like structure consisting of intertwined disordered and ordered regions at its C-terminal half. The aim of this study was to investigate the impact of two other potential ligands: Mg(2+), which possesses chemical properties similar to those of Ca(2+), and Zn(2+), for which a putative binding motif was identified. In this study, we demonstrated that the binding of Mg(2+) led to oligomerization state changes with no significant secondary or tertiary structural alterations of Nucb2. In contrast, Zn(2+) binding had a more pronounced effect on the structure of Nucb2, leading to the local destabilization of its N-terminal half while also inducing changes within its C-terminal half. These structural rearrangements resulted in the oligomerization and/or aggregation of Nucb2 molecules. Taken together, the results of our previous and current research help to elucidate the structure of the Nucb2, which can be divided into two parts: the Zn(2+)-sensitive N-terminal half (consisting of nesfatin-1 and -2) and the Ca(2+)-sensitive C-terminal half (consisting of nesfatin-3). These results may also help to open a new discussion regarding the diverse roles that metal cations play in regulating the structure of Nucb2 and the various physiological functions of this protein.
format Online
Article
Text
id pubmed-8361300
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-83613002021-08-23 Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3 Bystranowska, Dominika Skorupska, Anna Sołtys, Katarzyna Padjasek, Michał Krężel, Artur Żak, Andrzej Kaus-Drobek, Magdalena Taube, Michał Kozak, Maciej Ożyhar, Andrzej Comput Struct Biotechnol J Research Article Nucleobindin-2 (Nucb2) is a protein that has been suggested to play roles in a variety of biological processes. Nucb2 contains two Ca(2+)/Mg(2+)-binding EF-hand domains separated by an acidic amino acid residue-rich region and a leucine zipper. All of these domains are located within the C-terminal half of the protein. At the N-terminal half, Nucb2 also possesses a putative Zn(2+)-binding motif. In our recent studies, we observed that Nucb2 underwent Ca(2+)-dependent compaction and formed a mosaic-like structure consisting of intertwined disordered and ordered regions at its C-terminal half. The aim of this study was to investigate the impact of two other potential ligands: Mg(2+), which possesses chemical properties similar to those of Ca(2+), and Zn(2+), for which a putative binding motif was identified. In this study, we demonstrated that the binding of Mg(2+) led to oligomerization state changes with no significant secondary or tertiary structural alterations of Nucb2. In contrast, Zn(2+) binding had a more pronounced effect on the structure of Nucb2, leading to the local destabilization of its N-terminal half while also inducing changes within its C-terminal half. These structural rearrangements resulted in the oligomerization and/or aggregation of Nucb2 molecules. Taken together, the results of our previous and current research help to elucidate the structure of the Nucb2, which can be divided into two parts: the Zn(2+)-sensitive N-terminal half (consisting of nesfatin-1 and -2) and the Ca(2+)-sensitive C-terminal half (consisting of nesfatin-3). These results may also help to open a new discussion regarding the diverse roles that metal cations play in regulating the structure of Nucb2 and the various physiological functions of this protein. Research Network of Computational and Structural Biotechnology 2021-07-30 /pmc/articles/PMC8361300/ /pubmed/34429849 http://dx.doi.org/10.1016/j.csbj.2021.07.036 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Bystranowska, Dominika
Skorupska, Anna
Sołtys, Katarzyna
Padjasek, Michał
Krężel, Artur
Żak, Andrzej
Kaus-Drobek, Magdalena
Taube, Michał
Kozak, Maciej
Ożyhar, Andrzej
Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title_full Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title_fullStr Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title_full_unstemmed Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title_short Nucleobindin-2 consists of two structural components: The Zn(2+)-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca(2+)-sensitive C-terminal half, consisting of nesfatin-3
title_sort nucleobindin-2 consists of two structural components: the zn(2+)-sensitive n-terminal half, consisting of nesfatin-1 and -2, and the ca(2+)-sensitive c-terminal half, consisting of nesfatin-3
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361300/
https://www.ncbi.nlm.nih.gov/pubmed/34429849
http://dx.doi.org/10.1016/j.csbj.2021.07.036
work_keys_str_mv AT bystranowskadominika nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT skorupskaanna nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT sołtyskatarzyna nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT padjasekmichał nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT krezelartur nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT zakandrzej nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT kausdrobekmagdalena nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT taubemichał nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT kozakmaciej nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3
AT ozyharandrzej nucleobindin2consistsoftwostructuralcomponentsthezn2sensitiventerminalhalfconsistingofnesfatin1and2andtheca2sensitivecterminalhalfconsistingofnesfatin3